Cooper Companies | COO - Interest Expense On Debt


Cooper Companies reported $24.4M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Abbott USD 42M 2M Dec/2025
Align Technology USD 2M 660K Mar/2023
AtriCure USD 1.33M 17K Sep/2025
Avanos Medical USD 1.8M 200K Sep/2025
Bausch Health Companies USD 412M 53M Sep/2025
Baxter International USD 58M 14M Sep/2025
Bayer EUR 762M 267M Sep/2025
Becton, Dickinson and Co. USD 153M 2M Dec/2025
Boston Scientific USD 90M 3M Dec/2025
Cooper Companies USD 24.4M 1000K Sep/2025
Dentsply International USD 23M 1000K Sep/2025
Dexcom USD 4.7M 0 Sep/2025
Edwards Lifesciences USD 38.6M 1.2M Sep/2025
Globus Medical USD 5.1B 5.1B Sep/2025
Haemonetics USD 7.21M 3.14M Sep/2025
Hologic USD 27.6M 1000K Dec/2025
Inogen 1.03M 384K Mar/2025
Insulet USD 9.2M 2.2M Dec/2025
Integra LifeSciences USD 22.72M 1.68M Sep/2025
Intuitive Surgical USD 19.35B 811.4M Sep/2025
J&J USD 18M 290M Sep/2025
Medtronic USD 181M 0 Dec/2025
Merit Medical Systems USD 6.78M 207K Jun/2025
Novartis USD 281M 8M Sep/2025
ResMed USD 8.79M 14.55M Sep/2025
STAAR Surgical USD 1000 0 Dec/2024
Steris USD 14.9M 0 Dec/2025
Stryker USD 157M 46.17B Sep/2025
Tandem Diabetes Care USD 2.07M 872.58M Dec/2025
Teleflex USD 31.84M 10.13M Sep/2025
Zimmer Biomet Holdings USD 71.9M 3.5M Dec/2025